The updated recommendations represent a collaboration between the American College of Cardiology, American Heart Association and several other U.S. healthcare organizations. 

The randomized COBRRA trial included more than 2,700 patients with acute symptomatic pulmonary embolism or proximal deep-vein thrombosis. 

Researchers noted that these requirements are more common for Black and Hispanic patients, creating a critical barrier to guideline-recommended care.

When patients fear that GLP-1 drugs are “too new” to be trusted, cardiologists can make a world of difference by closely listening and then explaining how they work.

Students sometimes take unprescribed Adderall to stay up late and study. According to new research out of Mayo Clinic, however, that may do more to the heart than those students realize. 

When patients on GLP-1 therapy also make healthy lifestyle choices—getting enough sleep and exercising, for example—the benefits are significantly greater. 

MiniMed, Medtronic's diabetes business, hopes to sell 28 million shares of its common stock at a price of $25 to $28 per share.

The American Society for Preventive Cardiology celebrated researchers for uncovering new insights into this rare condition.